Drugs / CD3-/CD19- natural killer cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01639456 | Oct 2013 → Jan 2017 | acute myeloid leukemia | Masonic Cancer Center, University of Minnesota | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD3-/CD19- natural killer cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01639456 ↗ |
| Modality | Cell therapy | “natural killer (NK) cell based therapy” NCT01639456 ↗ |